W.H.O. Authorizes Indian-Made COVID-19 Vaccine

The agency granted an emergency use license to Covaxin, saying the two-dose regimen is about 78% effective at preventing severe COVID-19.

The World Health Organization granted an emergency use license Wednesday to a coronavirus vaccine developed in India, offering reassurance for a shot the country’s regulators allowed long before advanced safety and efficacy testing was completed.

The U.N. health agency said in a statement that it had authorized Covaxin, made by India’s Bharat Biotech. The action makes Covaxin the eighth COVID-19 vaccine to receive WHO's green light.

Related StoryGlobal Vaccination Efforts Slow With Multiple Issues To Blame